Table of Contents

company-logo

Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Cardiff Oncology Dividend Announcement

• Cardiff Oncology does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Cardiff Oncology dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Cardiff Oncology Dividend History

Cardiff Oncology Dividend Yield

Cardiff Oncology current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cardiff Oncology stock? Use our calculator to estimate your expected dividend yield:

Cardiff Oncology Financial Ratios

P/E ratio-2.66
PEG ratio-0.42
P/B ratio2.32
ROE-73.97%
Payout ratio-0.06%
Current ratio4.74
Quick ratio4.74
Cash Ratio1.04

Cardiff Oncology Dividend FAQ

Does Cardiff Oncology stock pay dividends?
Cardiff Oncology does not currently pay dividends to its shareholders.
Has Cardiff Oncology ever paid a dividend?
No, Cardiff Oncology has no a history of paying dividends to its shareholders. Cardiff Oncology is not known for its dividend payments.
Why doesn't Cardiff Oncology pay dividends?
There are several potential reasons why Cardiff Oncology would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Cardiff Oncology ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Cardiff Oncology has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Cardiff Oncology a dividend aristocrat?
Cardiff Oncology is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Cardiff Oncology a dividend king?
Cardiff Oncology is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Cardiff Oncology a dividend stock?
No, Cardiff Oncology is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Cardiff Oncology stocks?
To buy Cardiff Oncology you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Cardiff Oncology stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.